Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
Amit G. Singal(The University of Texas Southwestern Medical Center), William M. Lee(The University of Texas Southwestern Medical Center), Anna S. Lok(University of Michigan–Ann Arbor), Adam C. Yopp(Southwestern Medical Center), Beverley Adams‐Huet(Texas Tech University), Jorge A. Marrero(The University of Texas Southwestern Medical Center), Jasmin A. Tiro(The University of Texas Southwestern Medical Center), Mahendra Nehra(The University of Texas Southwestern Medical Center)
Cited by 227
Related Papers
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
|Hepatology|2003|4.3k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.1k
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
|Hepatology|2023|1.6k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Management of hepatitis B: 2000—Summary of a workshop
|Gastroenterology|2001|786